Zaprinast

CAS No. 37762-06-4

Zaprinast ( M&B 22948 )

Catalog No. M14302 CAS No. 37762-06-4

Zaprinast (M&B 22948) is a potent, cGMP-specific phosphodiesterase inhibitor with IC50 of 0.5-0.76 and 0.15 uM for PDE5 and PDE6 respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 50 In Stock
25MG 87 In Stock
50MG 155 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Zaprinast
  • Note
    Research use only, not for human use.
  • Brief Description
    Zaprinast (M&B 22948) is a potent, cGMP-specific phosphodiesterase inhibitor with IC50 of 0.5-0.76 and 0.15 uM for PDE5 and PDE6 respectively.
  • Description
    Zaprinast (M&B 22948) is a potent, cGMP-specific phosphodiesterase inhibitor with IC50 of 0.5-0.76 and 0.15 uM for PDE5 and PDE6 respectively, also is an agonist for GPR35 (EC50=16/840 nM for rat/human GPR35); weakly inhibits PDE9, PDE10, and PDE11 with IC50 of 10-30 uM; enhances the vasodilatory effects of nitric oxide in a range of vascular tissues by prolonging the cGMP-mediated activation of cGMP-dependent protein kinase; also reduces cellular 2HG levels by inhibiting the upstream enzyme glutaminase (GLS), reverses histone hypermethylation and soft-agar growth of IDH1-mutant cells.Asthma Discontinued
  • Synonyms
    M&B 22948
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    PDE
  • Research Area
    Inflammation/Immunology
  • Indication
    Asthma

Chemical Information

  • CAS Number
    37762-06-4
  • Formula Weight
    271.30
  • Molecular Formula
    C13H13N5O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1C(NN=N2)=C2NC(C3=CC=CC=C3OCCC)=N1
  • Chemical Name
    3,6-dihydro-5-(2-propoxyphenyl)-7H-1,2,3-triazolo[4,5-d]pyrimidin-7-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Elhammali A, et al. Cancer Discov. 2014 Jul;4(7):828-39.
2. Taniguchi Y, et al. FEBS Lett. 2006 Sep 18;580(21):5003-8.
3. Frossard N, et al. Br J Pharmacol. 1981 Aug;73(4):933-8.
4. Griffith TM, et al. Eur J Pharmacol. 1985 Jun 7;112(2):195-202.
molnova catalog
related products
  • (+)-Medioresinol Di-...

    (+)-Medioresinol Di-O-β-D-glucopyranoside has strong inhibitory activity of cyclic AMP phosphodiesterase.

  • Tofimilast

    Tofimilast (CP-325366) is a potent, selective PDE4 inhibitor with IC50 of 23, 13 and 13 nM for PDE4A, PDE4B, and PDE4D, respectively.

  • HT-0712

    HT-0712 (IPL-455903) is a novel potent, selective PDE4 inhibitor with IC50 of 0.15 uM for PDE4D3.